BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND MSN, P26038, 4478, ENSG00000147065
19 results:

  • 1. Ultrasound-Triggered Azo Free Radicals for cervical cancer Immunotherapy.
    Wang Y; Lv B; Wang H; Ren T; Jiang Q; Qu X; Ni D; Qiu J; Hua K
    ACS Nano; 2024 Apr; 18(17):11042-11057. PubMed ID: 38627898
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Selenium-driven enhancement of synergistic cancer chemo-/radiotherapy by targeting nanotherapeutics.
    Liu X; Yuan Z; Tang Z; Chen Q; Huang J; He L; Chen T
    Biomater Sci; 2021 Jul; 9(13):4691-4700. PubMed ID: 34019044
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A carboxymethyl lentinan layer by layer self-assembly system as a promising drug chemotherapeutic platform.
    Cai D; Shi L; Long R; Ren G; Wang S; Liu Y
    Carbohydr Polym; 2021 Jun; 261():117847. PubMed ID: 33766343
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Antiproliferative activity of standardized phytopreparations from Ibervillea sonorae (S. Watson) Greene.
    Vidal-Gutiérrez M; Torres-Moreno H; Hernández-Gutiérrez S; Velazquez C; Robles-Zepeda RE; Vilegas W
    Steroids; 2021 May; 169():108824. PubMed ID: 33727120
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Morin hydrate loaded solid lipid nanoparticles: Characterization, stability, anticancer activity, and bioavailability.
    Karamchedu S; Tunki L; Kulhari H; Pooja D
    Chem Phys Lipids; 2020 Nov; 233():104988. PubMed ID: 33035545
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A Review on Recent Technologies and Patents on Silica Nanoparticles for cancer Treatment and Diagnosis.
    Gupta A; Kushwaha SS; Mishra A
    Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery.
    Noureddine A; Maestas-Olguin A; Saada EA; LaBauve AE; Agola JO; Baty KE; Howard T; Sabo JK; Espinoza CRS; Doudna JA; Schoeniger JS; Butler KS; Negrete OA; Brinker CJ; Serda RE
    Acta Biomater; 2020 Sep; 114():358-368. PubMed ID: 32702530
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy.
    Herrera FG; Breuneval T; Prior JO; Bourhis J; Ozsahin M
    Radiat Oncol; 2016 Mar; 11():43. PubMed ID: 26984385
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Delivery of chemically glycosylated cytochrome c immobilized in mesoporous silica nanoparticles induces apoptosis in HeLa cancer cells.
    Méndez J; Morales Cruz M; Delgado Y; Figueroa CM; Orellano EA; Morales M; Monteagudo A; Griebenow K
    Mol Pharm; 2014 Jan; 11(1):102-11. PubMed ID: 24294910
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Stimulus-responsive controlled release system by covalent immobilization of an enzyme into mesoporous silica nanoparticles.
    Méndez J; Monteagudo A; Griebenow K
    Bioconjug Chem; 2012 Apr; 23(4):698-704. PubMed ID: 22375899
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
    Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC
    Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Tuning the cellular uptake and cytotoxicity properties of oligonucleotide intercalator-functionalized mesoporous silica nanoparticles with human cervical cancer cells HeLa.
    Vivero-Escoto JL; Slowing II; Lin VS
    Biomaterials; 2010 Feb; 31(6):1325-33. PubMed ID: 19932923
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells.
    Slowing I; Trewyn BG; Lin VS
    J Am Chem Soc; 2006 Nov; 128(46):14792-3. PubMed ID: 17105274
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer.
    Lyng H; Brøvig RS; Svendsrud DH; Holm R; Kaalhus O; Knutstad K; Oksefjell H; Sundfør K; Kristensen GB; Stokke T
    BMC Genomics; 2006 Oct; 7():268. PubMed ID: 17054779
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. New method of dynamic color doppler signal quantification in metastatic lymph nodes compared to direct polarographic measurements of tissue oxygenation.
    Scholbach T; Scholbach J; Krombach GA; Gagel B; Maneschi P; Di Martino E
    Int J Cancer; 2005 May; 114(6):957-62. PubMed ID: 15645426
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent.
    Radu DR; Lai CY; Jeftinija K; Rowe EW; Jeftinija S; Lin VS
    J Am Chem Soc; 2004 Oct; 126(41):13216-7. PubMed ID: 15479063
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Expression of glycolipids bearing Lewis phenotypes in tissues and cultured cells of human gynecological cancers.
    Takehara K; Kubushiro K; Kiguchi K; Ishiwata I; Tsukazaki K; Nozawa S; Iwamori M
    Jpn J Cancer Res; 2002 Oct; 93(10):1129-37. PubMed ID: 12417043
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [The mechanism of cytotoxicity of monoclonal antibodies to gynecological cancer cell-lines].
    Iida S; Nozawa S
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Jul; 42(7):667-74. PubMed ID: 2212803
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. msn-1 antibody in the evaluation of female genital tract adenocarcinomas.
    Poropatich C; Nozawa S; Rojas M; Chapman WB; Silverberg SG
    Int J Gynecol Pathol; 1990; 9(1):73-9. PubMed ID: 2294065
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.